ESSA Pharma Inc.
EPIX
$1.72
$0.010.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 89.85% | 82.41% | 20.26% | 15.68% | -11.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.52% | 7.64% | -3.06% | 27.79% | -3.42% |
| Operating Income | -27.52% | -7.64% | 3.06% | -27.79% | 3.42% |
| Income Before Tax | -43.05% | -15.94% | 0.89% | -27.36% | 11.53% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -43.05% | -15.94% | 0.89% | -27.33% | 11.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.05% | -15.94% | 0.89% | -27.33% | 11.53% |
| EBIT | -27.52% | -7.64% | 3.06% | -27.79% | 3.42% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -42.16% | -15.21% | 1.51% | -26.92% | 11.63% |
| Normalized Basic EPS | -42.13% | -15.19% | 1.55% | -26.87% | 11.61% |
| EPS Diluted | -42.16% | -15.21% | 1.51% | -26.92% | 11.63% |
| Normalized Diluted EPS | -42.13% | -15.19% | 1.55% | -26.87% | 11.61% |
| Average Basic Shares Outstanding | 0.59% | 0.62% | 0.62% | 0.33% | 0.13% |
| Average Diluted Shares Outstanding | 0.59% | 0.62% | 0.62% | 0.33% | 0.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |